Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/6/2025 | $470.00 → $520.00 | Overweight | Piper Sandler |
| 10/31/2024 | $500.00 → $495.00 | Outperform | BMO Capital Markets |
| 10/10/2024 | $515.00 → $500.00 | Buy | Goldman |
| 10/8/2024 | Outperform → Perform | Oppenheimer | |
| 9/23/2024 | $475.00 | Buy → Neutral | DA Davidson |
| 6/10/2024 | $570.00 | Buy | New Street |
| 6/7/2024 | $450.00 → $500.00 | Outperform | Oppenheimer |
| 4/17/2024 | $460.00 → $480.00 | Overweight | Wells Fargo |
SC 13G/A - MICROSOFT CORP (0000789019) (Subject)
SC 13G/A - MICROSOFT CORP (0000789019) (Subject)
REDMOND, Wash., Jan. 9, 2025 /PRNewswire/ -- Microsoft Corp. will publish fiscal year 2025 second-quarter financial results after the close of the market on Wednesday, Jan. 29, 2025, on the Microsoft Investor Relations website at https://www.microsoft.com/en-us/Investor/. A live webcast of the earnings conference call will be made available at 2:30 p.m. Pacific Time. Microsoft (Nasdaq "MSFT" @microsoft) creates platforms and tools powered by AI to deliver innovative solutions that meet the evolving needs of our customers. The technology company is committed to making AI availa
The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.Pioneering the Economics of Health to examine the interdependencies of the healthcare ecosystem which are often overlooked when only considering a singular silo of it.AI In Biopharma to highlight how AI-driven technologies can revolutionize drug discovery, accelerate development timelines, enhance patient accessibility, foster quicker innovation, and significantly reduce operating costs.Panelists to include David Rhew (Global Chief Medica
WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen" or "Tevogen Bio Holdings Inc.") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today the company will host an AI panel during the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The panel, titled "AI in Biopharma: Next Frontier of Medical Innovation," will explore the transformative potential of artificial intelligence in the biopharma industry. Panelists will include Dr. David Rhew, Global Chief Medical Officer & VP of Healthcare of Microsoft (NASDAQ:MSFT),
Piper Sandler reiterated coverage of Microsoft with a rating of Overweight and set a new price target of $520.00 from $470.00 previously
BMO Capital Markets reiterated coverage of Microsoft with a rating of Outperform and set a new price target of $495.00 from $500.00 previously
Goldman reiterated coverage of Microsoft with a rating of Buy and set a new price target of $500.00 from $515.00 previously
S-3ASR - MICROSOFT CORP (0000789019) (Filer)
8-K - MICROSOFT CORP (0000789019) (Filer)
8-K - MICROSOFT CORP (0000789019) (Filer)
4 - MICROSOFT CORP (0000789019) (Issuer)
4 - MICROSOFT CORP (0000789019) (Issuer)
4 - MICROSOFT CORP (0000789019) (Issuer)
USA News Group CommentaryIssued on behalf of Scope AI Corp. VANCOUVER, BC, June 21, 2024 /PRNewswire/ -- USA News Group – How we embrace this surging adoption of artificial intelligence (AI) in the economy of the future remains up for debate. Already, we're seeing the impact of AI adoption in the workplace, in culture, and in finance, but it won't end there. According to Goldman Sachs, AI is showing "very positive" signs of eventually boosting GDP and productivity, while some experts are remarking that the generative AI tech wave is sweeping in much faster (maybe 10x) than early internet. Behind the scenes, tech developers are building AI-powered tools that could potentially revolutionize pr
INSTANT®, a leading data automation and generative technology company specializing in real-time business intelligence for global enterprises and financial institutions, is delighted to announce the appointment of Rob Melnyk as Executive Vice President, Financial Services. With his extensive experience in leadership at high-growth investment management and capital markets firms, Rob brings a wealth of knowledge and expertise to the INSTANT leadership team. As Executive Vice President, Financial Services, Rob will spearhead efforts to refine the INSTANT Platform for Financial Services, assist with the product delivery sales process, drive strategic planning, and lead cross-organizational initi
Chairman of the Board Chris Hayes Appointed as President & CEO Dr. Audrey Lee joins the Board of Directors Spruce Power Holding Corporation (NYSE:SPRU) ("Spruce" or the "Company"), a leading owner and operator of distributed solar energy assets across the United States, today announced that Chris Hayes, Spruce's Chairman of the Board, will succeed Christian Fong as President and Chief Executive Officer, effective April 12, 2024. Additionally, Dr. Audrey Lee has joined the Board of Directors. "The Board is confident that Chris is the right leader to take Spruce to the next stage of its evolution and develop avenues of growth. Chris brings a wealth of experience to his role as CEO, incl
REDMOND, Wash., Jan. 9, 2025 /PRNewswire/ -- Microsoft Corp. will publish fiscal year 2025 second-quarter financial results after the close of the market on Wednesday, Jan. 29, 2025, on the Microsoft Investor Relations website at https://www.microsoft.com/en-us/Investor/. A live webcast of the earnings conference call will be made available at 2:30 p.m. Pacific Time. Microsoft (Nasdaq "MSFT" @microsoft) creates platforms and tools powered by AI to deliver innovative solutions that meet the evolving needs of our customers. The technology company is committed to making AI availa
REDMOND, Wash., Dec. 3, 2024 /PRNewswire/ -- Microsoft Corp. on Tuesday announced that its board of directors declared a quarterly dividend of $0.83 per share. The dividend is payable March 13, 2025, to shareholders of record on Feb. 20, 2025. The ex-dividend date will be Feb. 20, 2025. Microsoft (Nasdaq "MSFT" @microsoft) creates platforms and tools powered by AI to deliver innovative solutions that meet the evolving needs of our customers. The technology company is committed to making AI available broadly and doing so responsibly, with a mission to empower every person and e
REDMOND, Wash., Oct. 30, 2024 /PRNewswire/ -- Microsoft Corp. on Wednesday announced that fiscal year 2025 first-quarter financial results are available on its Investor Relations website. The direct link to the earnings press release is https://www.microsoft.com/en-us/Investor/earnings/FY-2025-Q1/press-release-webcast. As previously announced, the company will host a conference call at 2:30 p.m. Pacific Time. A live webcast of the call can be accessed on Microsoft's Investor Relations website at https://www.microsoft.com/en-us/Investor/. Microsoft (Nasdaq "MSFT" @microsoft)